Multidisciplinary Masterclass on Breast Cancer.

– Programa –

9 de julio de 2021.

14:45. Bienvenida. Dr Gérard Friedlander – University of Paris Foundation, France.

15:00. Imaging work-up of breast masses. Dr. Marc Abehsera – American Hospital of Paris, Neuilly sur Seine, France.
15:30. 2019 WHO updates on breast tumor classification. Dr Paula Ginter – Weill Cornell Medicine, New York, USA.
16:00. Tricky cases on breast core-needle biopsy. Dr Timothy d’Alfonso – Memorial Sloan Kettering Cancer Center, New York, USA.
17:00. Immunohistochemistry : diagnostic possibilities and pitfalls. Dr Emad Rakha – University of Nottingham & School of Medicine, Nottingham, United Kingdom.
17:30. Immunohistochemistry : theranostic purposes. Dr Paula Ginter – Weill Cornell Medicine, New York, USA.

10 de julio de 2021.

13:00. Treatment scenari of hormone-dependent breast cancer. Dr Mahasti Saghatchian – American Hospital of Paris, Neuilly sur Seine, France.
13:30. Treatment scenari of HER2-amplified breast cancer. Dr Leticia Varella – Weill Cornell Medicine, New York, USA.
14:00. Treatment scenari of triple-negative breast cancer. Dr Linda Vahdat – Memorial Sloan Kettering Cancer Center, New York, USA.
14:45. The future is here: artificial intelligence in routine breast pathology. Dr Daphna Laifenfeld – Ibex, Tel Aviv, Israel.
15:15. Somatic molecular tests a pathologist should know. Dr Jorge Reis-Filho – Memorial Sloan Kettering Cancer Center, New York, USA.
15:45. Genetic evaluation of breast cancer risk. Dr Dominique Stoppa-Lyonnet – Curie Institute Paris, University of Paris, France.
16:15. One stop clinic for breast masses. Dr Philippe Vielh – Medipath & American Hospital of Paris, Neuilly sur Seine, France.